New Key Statistics Module, Z-Score and F-Score
NYSE:BIO.B Key Ratios
Market Cap $ M | 8,033.38 |
Enterprise Value $ M | 7,787.44 |
P/E(ttm) | -- |
PE Ratio without NRI | 27.48 |
Forward PE Ratio | 25.91 |
Price/Book | 0.89 |
Price/Sales | 3.14 |
Price/Free Cash Flow | 44.18 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,605.00 |
EPS (TTM) $ | -10.36 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -19.74 |
EV-to-EBITDA | -31.52 |
PEG | -- |
Shares Outstanding M | 28.52 |
Net Margin (%) | -12.37 |
Operating Margin % | 12.31 |
Pre-tax Margin (%) | -17.04 |
Quick Ratio | 4.89 |
Current Ratio | 6.57 |
ROA % (ttm) | -2.58 |
ROE % (ttm) | -3.63 |
ROIC % (ttm) | 2.23 |
Dividend Yield % | -- |
Altman Z-Score | 2.78 |
BIO.B Number of Guru Trades
BIO.B Volume of Guru Trades
Gurus Latest Trades with NYSE:BIO.B
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BIO.B is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bio-Rad Laboratories Inc Insider Transactions
No Available Data
News about NYSE:BIO.B
Total 0- 1